<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001513'>Obesity</z:hpo>, <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo>, elevated <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are major risk factors for <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Hamsters, unlike rats or mice, respond well to diet-induced <z:hpo ids='HP_0001513'>obesity</z:hpo>, increase body mass and <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> on group housing, and increase food intake due to social confrontation-induced stress </plain></SENT>
<SENT sid="2" pm="."><plain>They have a cardiovascular and hepatic system similar to that of humans, and can thus be a useful model for human pathophysiology </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Experiments were planned to develop a diet-induced Bio F(1)B Golden Syrian hamster model of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> and associated nonalcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease in the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Hamsters were fed a <z:mpath ids='MPATH_458'>normal</z:mpath> control diet, a high-fat/high-cholesterol diet, a high-fat/high-cholesterol/methionine-deficient/<z:chebi fb="3" ids="15354">choline</z:chebi>-devoid diet, and a high-fat/high-cholesterol/<z:chebi fb="3" ids="15354">choline</z:chebi>-deficient diet </plain></SENT>
<SENT sid="5" pm="."><plain>Serum total cholesterol, <z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi>, <z:chebi fb="1" ids="47774">low-density lipoprotein cholesterol</z:chebi>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, atherogenic index, and body weight were quantified biweekly </plain></SENT>
<SENT sid="6" pm="."><plain>Fat deposition in the liver was observed and assessed following <z:chebi fb="23" ids="18059">lipid</z:chebi> staining with <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin and with oil red O </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: In this study, we established a diet-induced Bio F(1)B Golden Syrian hamster model for studying <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> and associated nonalcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease in the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0003077'>Hyperlipidemia</z:hpo> and elevated serum <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations were induced using this diet </plain></SENT>
<SENT sid="9" pm="."><plain>Atherogenic index was elevated, increasing the risk for a cardiovascular event </plain></SENT>
<SENT sid="10" pm="."><plain>Histological analysis of liver specimens at the end of four weeks showed increased fat deposition in the liver of animals fed with a high-fat/high cholesterol diet, as compared to animals fed with the control diet </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Our study established that hamsters fed with a high-fat/high-cholesterol diet developed <z:hpo ids='HP_0001397'>fatty liver</z:hpo> and mild <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>Bio F(1)B hamsters fed with a high-fat/high-cholesterol diet may thus be a good animal model for research on the treatment of diet-induced <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> complicated by nonalcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease </plain></SENT>
</text></document>